Jácome Cristina, Marques Alda
Research Centre in Physical Activity, Health and Leisure, Faculty of Sports, University of Porto, Porto, Portugal, and the School of Health Sciences, University of Aveiro, Aveiro, Portugal.
Respir Care. 2014 Apr;59(4):588-94. doi: 10.4187/respcare.02742. Epub 2013 Oct 8.
Pulmonary rehabilitation (PR) is effective in improving exercise capacity and health-related quality of life (HRQOL) in patients with moderate-to-very-severe COPD. Quadriceps strength and HRQOL can be impaired in patients with mild COPD, therefore, patients at this grade may already benefit from PR. However, the impact of PR in patients with mild COPD remains unestablished. Thus, this systematic review assessed the impact of PR on exercise capacity, HRQOL, health-care resource use and lung function in patients with mild COPD.
The Web of Knowledge, EBSCO, MEDLINE, and SCOPUS databases were searched up to April 2013. Reviewers independently selected studies according to the eligibility criteria.
Three studies with different designs (retrospective, one group pretest-posttest, and randomized controlled trial) were included. Out-patient PR programs were implemented in two studies, which included mainly aerobic, strength, and respiratory muscle training. The randomized controlled trial compared a PR home-based program, consisting of 6 months of walking and participating in ball games, with standard medical treatment. Significant improvements in exercise capacity (effect size [ES] 0.87-1.82) and HRQOL (ES 0.24-0.86) were found when comparing pretest-posttest data and when comparing PR with standard medical treatment. In one study, a significant decrease in hospitalization days was found (ES 0.38). No significant effects were observed on the number of emergency department visits (ES 0.32), number of hospitalizations (ES 0.219), or lung function (ES 0.198).
Most of the PR programs had significant positive effects on exercise capacity and HRQOL in patients with mild COPD; however, their effects on health-care resource use and lung function were inconclusive. This systematic review suggests that patients with mild COPD may benefit from PR; however, insufficient evidence is still available. Studies with robust designs and with longer follow-up times should be conducted.
肺康复(PR)对于改善中重度慢性阻塞性肺疾病(COPD)患者的运动能力和健康相关生活质量(HRQOL)有效。轻度COPD患者的股四头肌力量和HRQOL可能受损,因此,该级别患者可能已从PR中获益。然而,PR对轻度COPD患者的影响尚未明确。因此,本系统评价评估了PR对轻度COPD患者运动能力、HRQOL、医疗资源利用和肺功能的影响。
检索截至2013年4月的Web of Knowledge、EBSCO、MEDLINE和SCOPUS数据库。 reviewers根据纳入标准独立选择研究。
纳入了三项设计不同的研究(回顾性研究、单组前后测研究和随机对照试验)。两项研究实施了门诊PR项目,主要包括有氧运动、力量训练和呼吸肌训练。随机对照试验将一个为期6个月的居家PR项目(包括步行和参加球类游戏)与标准药物治疗进行了比较。比较前后测数据以及将PR与标准药物治疗进行比较时,发现运动能力(效应量[ES]0.87 - 1.82)和HRQOL(ES 0.24 - 0.86)有显著改善。在一项研究中,发现住院天数显著减少(ES 0.38)。在急诊科就诊次数(ES 0.32)、住院次数(ES 0.219)或肺功能(ES 0.198)方面未观察到显著影响。
大多数PR项目对轻度COPD患者的运动能力和HRQOL有显著的积极影响;然而,它们对医疗资源利用和肺功能的影响尚无定论。本系统评价表明轻度COPD患者可能从PR中获益;然而,仍缺乏足够的证据。应开展设计严谨、随访时间更长的研究。